Cardiff Oncology, Inc. - Common Stock, $0.0001 par value per share (CRDF)

Historical Holders from Q2 2020 to Q1 2025

Symbol
CRDF on Nasdaq
CUSIP
14147L108
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
67M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
28.1M
Holdings value
$122M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
116
Number of buys
65
Number of sells
-19
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardiff Oncology, Inc. - Common Stock, $0.0001 par value per share (CRDF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COMMODORE CAPITAL LP 8.1% $16.9M 5.38M COMMODORE CAPITAL LP Dec 10, 2024
BlackRock, Inc. 4.3% $8.92M 2.84M BlackRock, Inc. Dec 31, 2024
PFIZER INC 3.6% $7.57M 2.41M Pfizer Inc. 13-5315170 Dec 31, 2024

Institutional Holders of Cardiff Oncology, Inc. - Common Stock, $0.0001 par value per share (CRDF)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 322K $1.01M +$428K $3.14 11
2024 Q4 28.1M $122M +$50.1M $4.34 116
2024 Q3 12.8M $34.1M -$900K $2.67 83
2024 Q2 12.8M $28.4M +$5.43M $2.22 89
2024 Q1 8.58M $45.8M +$17.6M $5.34 75
2023 Q4 5.28M $7.81M -$209K $1.48 53
2023 Q3 5.42M $7.54M -$761K $1.39 55
2023 Q2 5.96M $8.76M -$1.4M $1.47 48
2023 Q1 7.03M $11.6M -$750K $1.65 50
2022 Q4 7.68M $10.8M -$321K $1.40 53
2022 Q3 7.92M $12.2M -$1.96M $1.54 48
2022 Q2 7.86M $17.3M -$14.1M $2.20 49
2022 Q1 13.8M $34.2M -$29.2M $2.48 78
2021 Q4 21.4M $128M +$2.41M $6.01 78
2021 Q3 21M $140M -$33.6M $6.66 84
2021 Q2 26.4M $175M +$10.1M $6.65 83
2021 Q1 24.1M $223M -$73.1M $9.26 69
2020 Q4 25.7M $462M +$144M $17.99 74
2020 Q3 18.7M $265M +$208M $14.19 61
2020 Q2 4.92M $24.7M +$24.7M $5.01 22